Relmada Therapeutics, Inc. (RLMD)

NASDAQ: RLMD · IEX Real-Time Price · USD

4.160

+0.105 (2.59%)

At close: Jul 19, 2024, 12:00 AM

4.100

-0.060 (-1.44%)

Pre-market: Jul 22, 2024, 8:07 AM EDT

Relmada Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2015
Market Capitalization	126	125	105	395	521	401	Upgrade
Market Cap Growth	106.26%	18.62%	-73.40%	-24.17%	29.98%	3061.80%	Upgrade
Enterprise Value	42	28	-43	183	404	284	Upgrade
PE Ratio	-	-1.26	-0.67	-3.14	-8.76	-26.71	Upgrade
PB Ratio	1.74	1.46	0.75	1.90	4.93	3.46	Upgrade
P/FCF Ratio	-2.91	-2.41	-1.01	-4.30	-18.73	-33.14	Upgrade
P/OCF Ratio	-2.91	-2.41	-1.01	-4.30	-18.73	-33.14	Upgrade
EV/EBITDA Ratio	-0.60	-0.29	0.28	-1.46	-6.79	-19.09	Upgrade
EV/EBIT Ratio	-0.60	-0.29	0.28	-1.46	-6.79	-19.09	Upgrade
EV/FCF Ratio	-1.18	-0.55	0.42	-1.99	-14.52	-23.52	Upgrade
Debt / Equity Ratio	-	-	-	-	-	0.00	Upgrade
Debt / EBITDA Ratio	-	-	-	-	-	-0.01	Upgrade
Debt / FCF Ratio	-	-	-	-	-	-0.01	Upgrade
Quick Ratio	6.76	7.90	11.94	14.08	9.30	80.04	Upgrade
Current Ratio	6.83	8.00	12.26	14.83	9.37	80.21	Upgrade
Interest Coverage	-	-	-	-	-	-143.13	Upgrade
Return on Equity (ROE)	-102.10%	-93.40%	-88.00%	-107.30%	-50.30%	-46.30%	Upgrade
Return on Assets (ROA)	-91.30%	-85.10%	-80.40%	-95.10%	-48.20%	-43.30%	Upgrade
Return on Capital (ROIC)	-136.77%	-121.49%	-114.82%	-60.36%	-57.62%	-13.05%	Upgrade
Earnings Yield	-75.12%	-79.28%	-149.50%	-31.84%	-11.41%	-3.74%	Upgrade
FCF Yield	-38.39%	-41.46%	-98.82%	-23.26%	-5.34%	-3.02%	Upgrade
Buyback Yield / Dilution	-0.11%	-1.59%	-68.80%	-12.56%	-68.75%	-194.65%	Upgrade
Total Shareholder Return	-0.11%	-1.59%	-68.80%	-12.56%	-68.75%	-194.65%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).